Target intelligence / Profile preview

Skin microbiome and epidermal barrier

Molecular classification
Other
01

Overview

The skin microbiome and epidermal barrier represent an integrated biological system essential for maintaining cutaneous homeostasis and protecting against environmental stressors. The epidermal barrier, primarily composed of the stratum corneum and tight junctions, provides a physical and chemical shield, while the microbiome consists of a diverse community of commensal microorganisms that modulate host immunity and inhibit pathogen colonization (Byrd et al., 2018). Dysregulation of this system, characterized by barrier defects or microbial dysbiosis (e.g., Staphylococcus aureus overgrowth), is a primary driver of inflammatory conditions such as atopic dermatitis and acne (Kong et al., 2012). Therapeutic approaches targeting this system do not typically hit a single receptor but rather aim to restore the ecosystem through the use of emollients, prebiotics, probiotics, and targeted antimicrobials (Dréno et al., 2016). Because this entity encompasses a complex environment of host cells and microbial species, it is classified as a biological system rather than a discrete molecular target (Elias, 2005).

Other names
Cutaneous microbiomeSkin floraSkin barrier systemStratum corneum barrier
02

Mechanism of action

Modulation of the cutaneous microbial ecosystem and reinforcement of the physical stratum corneum barrier to restore homeostasis.

03

Biological functions

Barrier functionImmune responseAntimicrobial defenseHomeostasis
04

Disease associations

Atopic dermatitisAcne vulgarisPsoriasisRosaceaInfectionInflammation
05

Safety considerations

Risk of opportunistic infectionInduction of dysbiosisSystemic absorption of topicals through barrier breachContact dermatitis
06

Interacting drugs

Ceramides

5 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Filaggrin expression levelsMicrobial Shannon diversity indexSkin surface pH

Beyond the preview

Go deeper on Skin microbiome and epidermal barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin microbiome and epidermal barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call